Mediclin AG
XETRA:MED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.3
2.96
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Mediclin AG
Mediclin AG
Cash & Cash Equivalents
Mediclin AG
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mediclin AG
XETRA:MED
|
Cash & Cash Equivalents
€130m
|
CAGR 3-Years
5%
|
CAGR 5-Years
35%
|
CAGR 10-Years
18%
|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Cash & Cash Equivalents
€299.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-18%
|
|
|
M1 Kliniken AG
XETRA:M12
|
Cash & Cash Equivalents
€10.3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Cash & Cash Equivalents
€3.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Cash & Cash Equivalents
€2.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
M
|
MedNation AG
SWB:EIF
|
Cash & Cash Equivalents
€2.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
Mediclin AG
Glance View
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
See Also
What is Mediclin AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
130m
EUR
Based on the financial report for Sep 30, 2024, Mediclin AG's Cash & Cash Equivalents amounts to 130m EUR.
What is Mediclin AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
18%
Over the last year, the Cash & Cash Equivalents growth was 19%. The average annual Cash & Cash Equivalents growth rates for Mediclin AG have been 5% over the past three years , 35% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
